tirzepatide recall Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide vs. Semaglutide: What You

Inagaki N, Seino Y, Takeda J, Yano H, Yamada Y, Bell GI, et al

3 In January 2026, the MHRA approved a higher dose of Wegovy, 7.2 mg, for adults with obesity (BMI of 30 or above)

Table of Contents Understanding hyperuricemia and gout in metabolic disease How GLP-1 therapies work in the body Evidence linking GLP-1 drugs to uric acid reduction Clinical implications for long-term gout risk Understanding Hyperuricemia and Gout in Metabolic Disease Hyperuricemia occurs when uric acid builds up in the blood, often leading to crystal formation in joints

Additionally, reduced food intake during semaglutide treatment means less overall bulk in your intestinal system, which can further contribute to slower transit

So nutritional counseling may be essential to help these people find a happy medium to continue a healthier lifestyle once the pounds are off

Energy and Activity Levels During GLP-1 Treatment Some days you might feel surprisingly energetic